Boston Scientific Corp revenue growth has been varied year-over-year.

What is BSX's revenue growth rate?

Historical revenue data is available for Boston Scientific Corp to analyze growth trends.

How fast is BSX earnings growing?

Earnings growth data is available for Boston Scientific Corp analysis.

What is BSX's profit margin?

Profit margin data is available for Boston Scientific Corp.

BSX Revenue & Earnings Growth Analysis 2026 - Is Boston Scientific Corp Growing?

Growth Summary

Boston Scientific Corp (BSX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.

Over the past 4 years, Boston Scientific Corp has achieved a revenue compound annual growth rate (CAGR) of 14.0%.

Latest Revenue

$16.75B

Net Income

$1.85B

5-Year Revenue CAGR

14.0%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Boston Scientific Corp

The chart above illustrates Boston Scientific Corp's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Boston Scientific Corp's business.

Profit Margin Trends

How efficiently Boston Scientific Corp converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Boston Scientific Corp retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$3.46

Current: $1.26

EPS Estimate 2027

$3.92

13.1% expected growth

Price Target

$104.75

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Boston Scientific Corp to continue growing earnings in the coming year. The consensus analyst rating is 4.5882 based on 34 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Boston Scientific Corp (BSX) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 14.0% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Boston Scientific Corp's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.